Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $849.29 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $251.63 | 18 | $0 (2024) |
| ABBVIE INC. | $209.52 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $108.67 | 5 | $0 (2024) |
| Mindray DS USA, Inc. | $91.82 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $47.77 | 3 | $0 (2024) |
| ACACIA PHARMA INC | $38.34 | 2 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $34.58 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $28.94 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $20.67 | 1 | $0 (2023) |
| Mauna Kea Technologies, Inc. | $17.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $631.90 | 41 | Takeda Pharmaceuticals U.S.A., Inc. ($236.50) |
| 2023 | $53.90 | 3 | Regeneron Healthcare Solutions, Inc. ($20.67) |
| 2022 | $163.49 | 8 | Mindray DS USA, Inc. ($91.82) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| 07/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/30/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 479 | 481 | $367,817 | $47,629 |
| 2022 | 6 | 103 | 108 | $330,544 | $14,962 |
| 2021 | 5 | 95 | 98 | $307,151 | $15,297 |
| 2020 | 6 | 119 | 125 | $283,712 | $20,514 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 268 | 268 | $198,770 | $26,008 | 13.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 87 | 89 | $71,554 | $8,663 | 12.1% |
| 00902 | Anesthesia for procedure on anus and rectum | Facility | 2023 | 46 | 46 | $40,943 | $5,058 | 12.4% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 51 | 51 | $31,330 | $4,724 | 15.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 27 | 27 | $25,220 | $3,176 | 12.6% |
| 00670 | Anesthesia for extensive surgery on spine | Facility | 2022 | 11 | 11 | $74,712 | $4,148 | 5.6% |
| 00790 | Anesthesia for other procedure on upper abdomen | Facility | 2022 | 17 | 17 | $80,372 | $3,873 | 4.8% |
| 01938 | Anesthesia for injection, drainage or aspiration procedures on spine or spinal cord of lower back accessed through skin using imaging guidance | Facility | 2022 | 25 | 30 | $58,581 | $2,110 | 3.6% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Facility | 2022 | 24 | 24 | $50,657 | $2,076 | 4.1% |
| 00918 | Anesthesia for fragmenting, manipulation and/or removal of kidney stone including use of an endoscope | Facility | 2022 | 13 | 13 | $37,639 | $1,768 | 4.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 13 | 13 | $28,583 | $987.54 | 3.5% |
| 00670 | Anesthesia for procedure on spine and spinal cord | Facility | 2021 | 11 | 12 | $88,236 | $4,940 | 5.6% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2021 | 38 | 40 | $89,908 | $4,208 | 4.7% |
| 00790 | Anesthesia for procedure in upper abdomen including use of an endoscope | Facility | 2021 | 15 | 15 | $63,247 | $3,386 | 5.4% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Facility | 2021 | 18 | 18 | $37,131 | $1,529 | 4.1% |
| 00910 | Anesthesia for procedure on urinary system including use of an endoscope | Facility | 2021 | 13 | 13 | $28,629 | $1,235 | 4.3% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2020 | 50 | 56 | $99,636 | $7,020 | 7.0% |
| 00670 | Anesthesia for procedure on spine and spinal cord | Facility | 2020 | 12 | 12 | $67,266 | $4,860 | 7.2% |
| 00790 | Anesthesia for procedure in upper abdomen including use of an endoscope | Facility | 2020 | 15 | 15 | $47,918 | $3,652 | 7.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 17 | 17 | $33,638 | $2,433 | 7.2% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Facility | 2020 | 13 | 13 | $15,905 | $1,344 | 8.4% |
| 00910 | Anesthesia for procedure on urinary system including use of an endoscope | Facility | 2020 | 12 | 12 | $19,350 | $1,205 | 6.2% |
About Lance Attaway, CRNA
Lance Attaway, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1831375096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lance Attaway, CRNA has received a total of $849.29 in payments from pharmaceutical and medical device companies, with $631.90 received in 2024. These payments were reported across 52 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($849.29).
As a Medicare-enrolled provider, Attaway has provided services to 796 Medicare beneficiaries, totaling 812 services with total Medicare billing of $98,402. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Texarkana, TX
- Active Since 01/17/2008
- Last Updated 09/27/2023
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1831375096
Products in Payments
- ENTYVIO (Biological) $212.23
- LINZESS (Drug) $169.65
- A9 (Device) $91.82
- STELARA (Biological) $81.59
- OCALIVA (Drug) $34.58
- BRIDION (Drug) $33.33
- VOQUEZNA (Drug) $28.94
- TREMFYA (Drug) $27.08
- CREON (Drug) $23.59
- DUPIXENT (Biological) $20.67
- BARHEMSYS (Drug) $19.42
- BYFAVO (Drug) $18.92
- EOHILIA (Drug) $18.13
- SKYRIZI (Biological) $16.28
- DIFICID (Drug) $14.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Texarkana
Albert Scates, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,624
Jessica Huett, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $777.32
Tammy Ward, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $657.86
Yesenia Canciobello, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $246.45
Gary Jackson, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $236.03
Justin Fitts, C.r.n.a, C.R.N.A
Nurse Anesthetist, Certified Registered — Payments: $233.44